Table 2. Crude Incidence Rates and Characteristics of Hematologic Malignant Neoplasm Types Among Breast Cancer Survivors .
| Type | Cases, No. (%) (n = 3406) | Crude Incidence Rate per 100 000 Person-Years (95% CI) | Median (IQR), y | |
|---|---|---|---|---|
| Age at Breast Cancer Diagnosis | Time From Breast Cancer Diagnosis to Hematologic Malignant Neoplasms | |||
| Myeloid neoplasm | ||||
| Acute myeloid leukemia | 509 (16.7) | 24.5 (22.4-26.8) | 63 (54-72) | 2.4 (1.4-4.0) |
| Myelodysplastic syndrome | 832 (27.3) | 40.1 (37.4-42.9) | 72 (62-79) | 3.2 (1.5-5.2) |
| Myeloproliferative neoplasm | 267 (8.8) | 12.8 (11.4-14.5) | 68 (58-75) | 3.3 (1.8-5.5) |
| Lymphoid neoplasm | ||||
| Multiple myeloma | 420 (13.8) | 20.3 (18.4-22.3) | 68 (59-75) | 3.0 (1.3-4.9) |
| Hodgkin/non–Hodgkin lymphoma | 912 (29.9) | 44.4 (41.1-50.0) | 68 (58-76) | 3.2 (1.4-5.2) |
| Acute lymphoblastic leukemia/lymphocytic lymphoma | 106 (3.5) | 5.1 (4.2-6.2) | 59.5 (50-69) | 2.5 (1.3-4.0) |
Abbreviation: IQR, interquartile range.